1-10 of 10
Valentina Ivanova
Close
Sort by
Journal Articles

Evolution of Platelet Function and Bleeding in Children and Adults with Chronic Immune Trombocytopenia on Romiplostim Treatment

Anastasia Ignatova, Elena Suntsova, Pavel Zharkov, Valentina Ivanova, Irina Demina, Aleksandr Poletaev, Elena Seregina, Dmitrii Polokhov, MD, Natalia Smetanina, Alexey A Maschan, MD PhD Professor, Mikhail Maschan, PhD, Galina Novichkova, Mikhail Panteleev, PhD Dr.Sc, Prof.
Journal: Blood
Blood (2017) 130 (Supplement 1): 3636.
https://doi.org/10.1182/blood.V130.Suppl_1.3636.3636
Published: 2017
Journal Articles

Effect of Eculizumab on Physician-Reported Symptoms in the Russian Cohort of the Paroxysmal Nocturnal Hemoglobinuria (PNH) International Registry

Igor Lisukov, Alexander Kulagin, Alexey Maschan, MD, Elena Shilova, MD, Kudrat Abdulkadyrov, MD, Andrey Zaritskiy, MD, Valentina Ivanova, MD, Yulia Bogdanova, Svetlana Volkova, MD, Andrey Gavrilenko, MD, Tatyana Kaporskaya, Sergey Meresiy, MD, Tatyana Schneider, MD, Svetlana Yakupova, MD, Ludmila Anchukova, MD, Bulat Bakirov, MD, Natalia Kosacheva, MD, Tatiana Krinitsina, MD, Viktoria Ustyantseva, MD, Yuriy Shatokhin, MD, Elena Vinogradova, MD, Tatiana Kazankova, MD, Alexander Rumyantsev, MD, Boris Afanasyev, MD
Journal: Blood
Blood (2014) 124 (21): 5163.
https://doi.org/10.1182/blood.V124.21.5163.5163
Published: 2014
Journal Articles

MM-003 Phase 3 Study Of Pomalidomide In Combination With Low-Dose Dexamethasone (POM + LoDEX) Vs High-Dose Dexamethasone (HiDEX) In Relapsed/Refractory Multiple Myeloma (RRMM): POM + Lodex Is Beneficial For Elderly Patients (> 65 Years of Age)

Katja Weisel, MD, Jesús F. San Miguel, MD, PhD, Kevin W. Song, MD, FRCPC, Michel Delforge, MD, PhD, Lionel Karlin, MD, Hartmut Goldschmidt, MD, Philippe Moreau, MD, Anne Banos, MD, Albert Oriol, MD, Laurent Garderet, MD, Michele Cavo, MD, Valentina Ivanova, MD, PhD, Adrian Alegre, MD, Joaquin Martinez-Lopez, Christine I. Chen, MD, Stefan Knop, MD, Xin Yu, PhD, Latisha Watkins, Lars Sternas, MD, Christian Jacques, MD, Mohamed H. Zaki, MD, PhD, Meletios A. Dimopoulos, MD
Journal: Blood
Blood (2013) 122 (21): 3198.
https://doi.org/10.1182/blood.V122.21.3198.3198
Published: 2013
Journal Articles

Data From The Russian Cohort Of The International Disease Registry For Paroxysmal Nocturnal Hemoglobinuria (PNH)

Igor Lisukov, Alexander Kulagin, Alexey Maschan, MD, Elena Shilova, Kudrat Abdulkadyrov, Andrey Zaritskiy, Valentina Ivanova, Yulia Bogdanova, Svetlana Volkova, Andrey Gavrilenko, Tatyana S Kaporskaya, Sergey Meresiy, Tatyana Schneider, Svetlana Yakupova, Ludmila Anchukova, Bulat Bakirov, MD, Natalia Kosacheva, Tatiana Krinitsina, Viktoria Ustyantseva, Yuriy Shatokhin, Alexander Rumyantsev, Boris Afanasyev
Journal: Blood
Blood (2013) 122 (21): 4866.
https://doi.org/10.1182/blood.V122.21.4866.4866
Published: 2013
Journal Articles

Patient Outcomes By Prior Therapies and Depth Of Response: Analysis Of MM-003, a Phase 3 Study Comparing Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) Vs High-Dose Dexamethasone (HiDEX) In Relapsed/Refractory Multiple Myeloma (RRMM)

Jesús F. San Miguel, MD, PhD, Katja Weisel, MD, Kevin W. Song, MD, FRCPC, Michel Delforge, MD, PhD, Lionel Karlin, MD, Hartmut Goldschmidt, MD, Philippe Moreau, MD, Anne Banos, MD, Albert Oriol, MD, Laurent Garderet, MD, Michele Cavo, MD, Valentina Ivanova, MD, PhD, Adrian Alegre, MD, Joaquin Martinez-Lopez, Christine I. Chen, MD, Christoph Renner, MD, Nizar J. Bahlis, MD, Xin Yu, PhD, Terri Teasdale, MS, Lars Sternas, MD, Christian Jacques, MD, Mohamed H. Zaki, MD, PhD, Meletios A. Dimopoulos, MD
Journal: Blood
Blood (2013) 122 (21): 686.
https://doi.org/10.1182/blood.V122.21.686.686
Published: 2013
Journal Articles

Final Analysis, Cytogenetics, Long-Term Treatment, and Long-Term Survival In MM-003, A Phase 3 Study Comparing Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) Vs High-Dose Dexamethasone (HiDEX) In Relapsed/Refractory Multiple Myeloma (RRMM)

Meletios A. Dimopoulos, MD, Katja Weisel, MD, Kevin W. Song, MD, FRCPC, Michel Delforge, MD, PhD, Lionel Karlin, MD, Hartmut Goldschmidt, MD, Philippe Moreau, MD, Anne Banos, MD, Albert Oriol, MD, Laurent Garderet, MD, Michele Cavo, MD, Valentina Ivanova, MD, PhD, Adrian Alegre, MD, Joaquin Martinez-Lopez, Christine I. Chen, MD, Andrew Spencer, MD, Stefan Knop, MD, Nizar J. Bahlis, MD, Christoph Renner, MD, Xin Yu, PhD, Kevin Hong, MS, Lars Sternas, MD, Christian Jacques, MD, Mohamed H. Zaki, MD, PhD, Jesús F. San Miguel, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 408.
https://doi.org/10.1182/blood.V122.21.408.408
Published: 2013
Journal Articles

Results of Tyrosine Kinase Inhibitors (TKI) Therapy of Patients (Pts) with Chronic Myeloid Leukemia (CML) In Clinical Practice Analysed In the Frame of International Research Project EUTOS In Russian Federation

Anna G. Turkina, MD, PhD, Sergey Kulikov, Kudrat Abdulkadirov, Sergey Kutsev, MD, PhD, Anatoly Golenkov, MD, Valentina Ivanova, Tatiana Pospelova, MD, PhD, Tatiana Konstantinova, Olga Lazareva, PhD, Nina Khoroshko, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4447.
https://doi.org/10.1182/blood.V118.21.4447.4447
Published: 2011
Journal Articles

Maintenance Rituximab Every 2 Months for 2 Years Is Effective and Well Tolerated In Patients with Follicular Lymphoma with Both Standard or Rapid Infusion: Updated Results From the Phase IIIb MAXIMA Study

Robin Foá, MD, Alice Di Rocco, Guy van Hazel, Dalton FA Chamone, Klaus Ruffert, Jacob M. Rowe, Luca Arcaini, Irina Poddubnaya, Anthony D. Ho, MD, FRCPC, Valentina Ivanova, Andrej Vranovsky, MD, Mathias Witzens-Harig
Journal: Blood
Blood (2010) 116 (21): 3945.
https://doi.org/10.1182/blood.V116.21.3945.3945
Published: 2010
Journal Articles

Safety and Efficacy in Patients Receiving Maintenance Rituximab for Follicular Lymphoma: Early Results From Phase IIIb MAXIMA Trial.

Mathias Witzens-Harig, Guy van Hazel, Dalton FA Chamone, Klaus Ruffert, Jacob M. Rowe, Mario Lazzarino, Robin Foà, Irina Poddubnaya, Anthony D. Ho, Valentina Ivanova, Andrej Vranowsky, Joachim Hipp, Stefan Oertel
Journal: Blood
Blood (2009) 114 (22): 3756.
https://doi.org/10.1182/blood.V114.22.3756.3756
Published: 2009
Journal Articles

The MAXIMA Study: Safety of Rituximab (MabThera®) Maintenance Therapy in Patients with Follicular Non-Hodgkin’s Lymphoma Who Have Responded to Induction Therapy.

Michael K. Wenger, MD, Robin Foa, MD, Luca Arcaini, MD, Andrej Vranovský, MD, Valentina Ivanova, MD, Van Hazel Guy, MD, Sabira Kurtovic, MD, Soledad Durán, MD, Stephen McKechnie, Daniel Thurley, MD
Journal: Blood
Blood (2007) 110 (11): 4475.
https://doi.org/10.1182/blood.V110.11.4475.4475
Published: 2007